{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:54:33Z","timestamp":1762001673286,"version":"3.37.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["neurotox res"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1007\/bf03033210","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T17:16:35Z","timestamp":1248110195000},"page":"545-556","source":"Crossref","is-referenced-by-count":34,"title":["Adenosine A2A receptor antagonists: Potential therapeutic and neuroprotective effects in parkinson\u2019s disease"],"prefix":"10.1007","volume":"3","author":[{"given":"M.","family":"Morelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wardas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03033210_CR1","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1523\/JNEUROSCI.20-15-05848.2000","volume":"20","author":"S. Aoyama","year":"2000","unstructured":"Aoyama, S., Kase, H. and Borelli, E. (2000) \u201cRescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist\u201d,J. Neurosci. 20, 5848\u20135852.","journal-title":"J. Neurosci."},{"key":"BF03033210_CR2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0361-9230(93)90233-2","volume":"31","author":"R.A. Barraco","year":"1993","unstructured":"Barraco, R.A., Martens, K.A., Parizon, M. and Normile, H.J. (1993) \u201cAdenosine A2a receptors in the nucleus accum-bens mediate locomotor depression\u201d,Brain Res. Bull. 31, 397\u2013404.","journal-title":"Brain Res. Bull."},{"key":"BF03033210_CR3","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0028-3908(97)00139-1","volume":"36","author":"E. Bona","year":"1997","unstructured":"Bona, E., Aden, U., Gilland, E., Fredholm, B.B. and Hagberg, H. (1997) \u201cNeonatal cerebral hypoxia ischemia: the effect of adenosine receptor antagonists\u201d,Neuropharmacology 36, 1327\u20131338.","journal-title":"Neuropharmacology"},{"key":"BF03033210_CR4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0028-3908(89)90037-3","volume":"28","author":"M. Casas","year":"1989","unstructured":"Casas, M., Ferre, S., Cobos, A., Grau, J.N. and Jane, F. (1989) \u201cRelationship between rotational behaviour induced by apomorphine and caffeine in rats with unilateral lesion of the nigrostriatal pathway\u201d,Neuropharmacology 28, 407\u2013409.","journal-title":"Neuropharmacology"},{"key":"BF03033210_CR5","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1523\/JNEUROSCI.19-21-09192.1999","volume":"19","author":"J.F. Chen","year":"1999","unstructured":"Chen, J.F., Huang, Z., Ma, J., Zhu, J.M., Moratalla, R., Standaert, D., Moskowitz, M.A., Fink, J.S. and Schwarzs-child, M.A. (1999) \u201cA2A adenosine receptors deficiency attenuate brain injury induced by transient focal ischemia in mice\u201d,J. Neurosci. 19, 9192\u20139200.","journal-title":"J. Neurosci."},{"key":"BF03033210_CR6","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1073\/pnas.98.4.1970","volume":"98","author":"J.F. Chen","year":"2001","unstructured":"Chen, J.F., Moratalla, R., Standaert, D., Impagnatiello, F., Grandy, D.K., Cuellar, B., Rubistein, M., Beilstein, M., Hackett, E., Fink, J.S., Low, M.J., Ongini, E. and Schwarzschild, M.A. (2001a) \u201cThe role of the D2 dopamine receptor (D2R) in A2A adenosine receptor (A2AR)-mediated behavioral and cellular responses as revealed by A2A and D2 receptor knockout mice\u201d,Proc. Natl. Acad. Sci. 98, 1970\u20131975.","journal-title":"Proc. Natl. Acad. Sci."},{"key":"BF03033210_CR7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","volume":"21","author":"J.F. Chen","year":"2001","unstructured":"Chen, J.F., Xu, K., Petzer, J.P., Staal, R., Xu, Y-H., Beilstein, M. A., Sonsalla, P.K., Castagnoli, K., Castagnoli, Jr, N. and Schwarzschild, Jr, M.A. (2001b) \u201cNeuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson\u2019s Disease\u201d,J. Neurosci. 21, 143.","journal-title":"J. Neurosci."},{"key":"BF03033210_CR8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0014-2999(96)00665-6","volume":"316","author":"S. Dasgupta","year":"1996","unstructured":"Dasgupta, S., Ferre, S., Kull, B., Hedlund, P.B., Finnman, U.B., Ahlberg, S., Arenas, E., Fredholm, B.B. and Fuxe, K. (1996) \u201cAdenosine A2A receptors modulate the binding characteristics of dopamine D2 receptors in stably cotransfected cells\u201d,Eur. J. Pharmacol. 316, 325\u2013331.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033210_CR9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1471-4159.1997.69010315.x","volume":"69","author":"A.K. Dixon","year":"1997","unstructured":"Dixon, A.K., Widdwson, P.J. and Richardson, P.J. (1997) \u201cDesensitisation of the adenosine Ai receptor by the A2A receptor in the striatum\u201d,J.Neurochem. 69, 315\u2013321.","journal-title":"J.Neurochem."},{"key":"BF03033210_CR10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0014-2999(89)90789-9","volume":"168","author":"M.J. Durcan","year":"1989","unstructured":"Durcan, M.J. and Morgan, P.F. (1989) \u201cEvidence for adenosine A2 receptor involvement in the hypomobility effects of adenosine analogues in mice\u201d,Eur. J. Pharmacol. 168, 285\u2013290.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033210_CR11","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1046\/j.1460-9568.1998.00198.x","volume":"10","author":"S. Fenu","year":"1998","unstructured":"Fenu, S. and Morelli, M. (1998) \u201cMotor stimulant effects of caffeine in 6-hydroxydopamine-lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of Dj and D2 receptors\u201d,Eur. Neurosci. 10, 1878\u20131884.","journal-title":"Eur. Neurosci."},{"key":"BF03033210_CR12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(96)00944-2","volume":"321","author":"S. Fenu","year":"1997","unstructured":"Fenu, S., Pinna, A., Ongini, E. and Morelli, M. (1997) \u201cAdenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats\u201d,Eur. J. Pharmacol. 321, 143\u2013147.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033210_CR13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002130050380","volume":"133","author":"S. Ferre","year":"1997","unstructured":"Ferre, S. (1997) \u201cAdenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia.\u201d,Psychopharmacology 133, 107\u2013120.","journal-title":"Psychopharmacology"},{"key":"BF03033210_CR14","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1073\/pnas.88.16.7238","volume":"88","author":"S. Ferre","year":"1991","unstructured":"Ferre, S., Von Euler, G., Johansson, B., Fredholm, B.B. and Fuxe, K. (1991) \u201cStimulation of high affinity adenosine A-2 receptors decreases the affinity of dopamine D-2 receptors in rat striatal membranes\u201d,Proc. Natl. Acad. Sci. USA. 88, 7238\u20137241.","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"BF03033210_CR15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0166-2236(97)01096-5","volume":"20","author":"S. Ferre","year":"1997","unstructured":"Ferre, S., Fredholm, B.B., Morelli, M., Popoli, P. and Fuxe, K. (1997) \u201cAdenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia\u201d,Trend Neurosci. 20, 482\u2013486.","journal-title":"Trend Neurosci."},{"key":"BF03033210_CR16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0169-328X(92)90173-9","volume":"14","author":"J.S. Fink","year":"1992","unstructured":"Fink, J.S., Weaver, D.R., Rivkees, S.A., Peterfreund, R.A., Pollack, A.E., Adler, E.M. and Reppert, S.M. (1992) \u201cMolecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum\u201d,Mol. Brain Res. 14, 186\u2013190.","journal-title":"Mol. Brain Res."},{"key":"BF03033210_CR17","first-page":"48","volume-title":"\u201cAdenosine receptors\u201d, IUPHAR Compendium of Receptor Characterization and Classification","author":"B.B. Fredholm","year":"1998","unstructured":"Fredholm, B.B., Ijzerman, A.P., Jacobson, K.A., Linden, J. and Stiles, G.L. (1998) \u201cAdenosine receptors\u201d, IUPHAR Compendium of Receptor Characterization and Classification (IUPHAR Media, London), pp. 48\u201357."},{"key":"BF03033210_CR18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","volume":"51","author":"B.B. Fredholm","year":"1999","unstructured":"Fredholm, B.B., Battig, K., Holmen, J., Nehlig, A. and Zvartau, E.E. (1999) \u201cActions of caffeine in the brain with special reference to factors that contribute to its widespread use\u201d,Pharmacol. Rev. 51, 83\u2013133.","journal-title":"Pharmacol. Rev."},{"key":"BF03033210_CR19","first-page":"48","volume":"52","author":"K. Fuxe","year":"1974","unstructured":"Fuxe, K. and Ungerstedt, U. (1974) \u201cAction of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists\u201d,Med. Biol. 52, 48\u201354.","journal-title":"Med. Biol."},{"key":"BF03033210_CR20","first-page":"61","volume":"55","author":"Y. Gao","year":"1994","unstructured":"Gao, Y. and Phillis, J.W. (1994) \u201cCGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischaemic injury in the Mongolian gerbil\u201d,Life Sci. 55, 61\u201365.","journal-title":"Life Sci."},{"key":"BF03033210_CR21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(96)00435-2","volume":"57","author":"B.E. Garrett","year":"1997","unstructured":"Garrett, B.E. and Griffiths, R.R. (1997) \u201cThe role of dopamine in the behavioral effects of caffeine in animals and humans\u201d,Pharmacol. Biochem. Behav. 57, 533\u2013541.","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BF03033210_CR22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0091-3057(94)90115-5","volume":"47","author":"B.E. Garrett","year":"1994","unstructured":"Garrett, B.E. and Holtzman, S.G. (1994a) \u201cDa and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats\u201d,Pharmacol. Biochem. Behav. 47, 89\u201394.","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BF03033210_CR23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-2999(94)90029-9","volume":"262","author":"B.E. Garrett","year":"1994","unstructured":"Garrett, B.E. and Holtzman, S.G. (1994b) \u201cCaffeine cross-tolerance to selective dopamine Dx and D2 receptor agonists but not to their synergistic interaction\u201d,Eur. J. Pharmacol. 262, 65\u201375.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033210_CR24","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","volume":"250","author":"C.R. Gerfen","year":"1990","unstructured":"Gerfen, C.R., Engber, T.M., Mahan, L.C., Susel, Z., Chase, T.N., Monsma, Jr, F.J. and Sibley, Jr, D.R. (1990) \u201cDl and D2 dopamine receptor-regulated gene expression of striato-nigral and striatopallidal neurons\u201d,Science 250, 1429\u20131432.","journal-title":"Science"},{"key":"BF03033210_CR25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/BF02244256","volume":"103","author":"G. Griebel","year":"1991","unstructured":"Griebel, G., Saffroy-Spittler, M., Misslin, R., Remmy, D., Vogel, E. and Bourguignon, J.J. (1991) \u201cComparison of the behavioral effects of an adenosine Al\/A2-receptor antagonist, CGS 5943A and an Al-selective antagonist, DPCPX\u201d,Psychopharmacology 103, 541\u2013544.","journal-title":"Psychopharmacology"},{"key":"BF03033210_CR26","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1212\/WNL.52.8.1673","volume":"52","author":"R. Grondin","year":"1999","unstructured":"Grondin, R., Bedard, P. J., Hadj Tahar, A., Gregoire, L., Mori, A. and Kase, H. (1999) \u201cAntiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys\u201d,Neurology 52, 1673\u20131677.","journal-title":"Neurology"},{"key":"BF03033210_CR27","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/00001756-199806010-00024","volume":"9","author":"W. Hauber","year":"1998","unstructured":"Hauber, W., Nagel, J., Sauer, R. and Muller, C.E. (1998) \u201cMotor effects induced by a blockade of adenosine A2A receptors in the caudate-putamen\u201d,Neroreport 9, 1803\u20131806.","journal-title":"Neroreport"},{"key":"BF03033210_CR28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00442002","volume":"98","author":"T.G. Heffner","year":"1989","unstructured":"Heffner, T.G., Wiley, J.N., Williams, A.E., Bruns, R.F., Coughenour, L.L. and Downs, D.A. (1989) \u201cComparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice\u201d,Psychopharmacology 98, 31\u201337.","journal-title":"Psychopharmacology"},{"key":"BF03033210_CR29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/exnr.1998.6819","volume":"151","author":"B. Henry","year":"1998","unstructured":"Henry, B., Crossman, A.R. and Brotchie, J.M. (1998) \u201cCharacterisation of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson\u2019s disease\u201d,Exp. Neurol. 151, 334\u2013342.","journal-title":"Exp. Neurol."},{"key":"BF03033210_CR30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF00735878","volume":"94","author":"M. Herrera-Marschitz","year":"1988","unstructured":"Herrera-Marschitz, M., Casas, M. and Ungerstedt, U. (1988) \u201cCaffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses\u201d,Psychopharmacology 94, 38\u201345.","journal-title":"Psychopharmacology"},{"key":"BF03033210_CR31","first-page":"71","volume":"50","author":"H. Higashi","year":"2000","unstructured":"Higashi, H., Marwaha, A.S., Memo, J.R. and Winn, H.R. (2000) \u201cCorrelation between hippocampal injury and neurobe-havior following normo- and hyperglycemic cerebral ischemia, effect of theophylline and ZM241385\u201d,Drug Dev. Res. 50, 71\u2013092.","journal-title":"Drug Dev. Res."},{"key":"BF03033210_CR32","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/0024-3205(91)90329-A","volume":"49","author":"S. Holtzman","year":"1991","unstructured":"Holtzman, S. and G,. (1991) \u201cCGS 15943, a non xanthine adenosine receptor antagonist: effects on locomotor activity of non tolerant and caffeine-tolerant rats\u201d,Life Sci. 49, 1563\u20131570.","journal-title":"Life Sci."},{"key":"BF03033210_CR33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0304-3940(00)01371-9","volume":"291","author":"M.J. Hurley","year":"2000","unstructured":"Hurley, M.J., Mash, D.C. and Jenner, P. (2000) \u201cAdenosine A2A receptor mRNA expression in Parkinson\u2019s disease\u201d,Neurosci. Lett. 291, 54\u201358.","journal-title":"Neurosci. Lett."},{"key":"BF03033210_CR34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0014-2999(89)90571-2","volume":"168","author":"M.F. Jarvis","year":"1989","unstructured":"Jarvis, M.F. and Williams, M. (1989) \u201cDirect autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680\u201d,Eur. J. Pharmacol. 168, 243\u2013246.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033210_CR35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0006-8993(93)90925-D","volume":"613","author":"H. Jiang","year":"1993","unstructured":"Jiang, H., Jackson-Lewis, V., Muthane, U., Dollison, A., Ferreira, M., Espinosa, A., Parsons, B. and Przedborski, S. (1993) \u201cAdenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats\u201d,Brain Res. 613, 347\u2013351.","journal-title":"Brain Res."},{"key":"BF03033210_CR36","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0006-8993(98)00540-X","volume":"800","author":"PA. Jones","year":"1998","unstructured":"Jones, PA., Smith, R.A. and Stone, T.W. (1998a) \u201cProtection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist\u201d,Brain Res. 800, 328\u2013335.","journal-title":"Brain Res."},{"key":"BF03033210_CR37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0306-4522(97)00613-1","volume":"85","author":"P.A. Jones","year":"1998","unstructured":"Jones, P.A., Smith, R.A. and Stone, T.W. (1998b) \u201cProtection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists\u201d,Neuroscience 85, 229\u2013237.","journal-title":"Neuroscience"},{"key":"BF03033210_CR38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0091-3057(91)90403-O","volume":"39","author":"S.A. Josselyn","year":"1991","unstructured":"Josselyn, S.A. and Beninger, R.J. (1991) \u201cBehavioral effects of intrastriatal caffeine mediated by adenosinergic modulation of dopamine\u201d,Pharmacol. Biochem. Behav. 39, 97\u2013103.","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BF03033210_CR39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0014-2999(95)00668-0","volume":"295","author":"S.H. Kafka","year":"1996","unstructured":"Kafka, S.H. and Corbett, R. (1996) \u201cSelective adenosine A2A receptor\/dopamine D2 receptor interactions in animal models of schizophrenia\u201d,Eur. Pharmacol. 295, 147\u2013154.","journal-title":"Eur. Pharmacol."},{"key":"BF03033210_CR40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0014-2999(94)90551-7","volume":"256","author":"T Kanda","year":"1994","unstructured":"Kanda, T, Shiozaki, S., Shimada, J., Suzuki, F. and Nakamura, J. (1994) \u201cKF17837: a novel selective adenosine A2A antagonist with anticataleptic activity\u201d,Eur. Pharmacol. 256, 263\u2013268.","journal-title":"Eur. Pharmacol."},{"key":"BF03033210_CR41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ana.410430415","volume":"43","author":"T. Kanda","year":"1998","unstructured":"Kanda, T., Jackson, M.J., Smith, L.A., Pearce, R.K.B., Nakamura, J., Kase, H., Kuwana, Y. and Jenner, P. (1998) \u201cAdenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys\u201d,Ann. Neurol. 43, 507\u2013513.","journal-title":"Ann. Neurol."},{"key":"BF03033210_CR42","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1212\/WNL.26.8.741","volume":"26","author":"R. Kartzinel","year":"1976","unstructured":"Kartzinel, R., Shoulson, I. and Calne, D.B. (1976) \u201cStudies with bromocriptine III. Concomitant administration of caffeine to patients with idopathic parkinsonism\u201d,Neurology 26, 741\u2013743.","journal-title":"Neurology"},{"key":"BF03033210_CR43","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1046\/j.1471-4159.1994.62030960.x","volume":"62","author":"LP. Kirk","year":"1994","unstructured":"Kirk, LP. and Richardson, P.J. (1994) \u201cAdenosine A2a receptor-mediated modulation of striatal [3H]GABA and [3H]Acetylcholine release\u201d,J. Neurochem 62, 960\u2013966.","journal-title":"J. Neurochem"},{"key":"BF03033210_CR44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1476-5381.1994.tb16171.x","volume":"113","author":"M Kurokawa","year":"1994","unstructured":"Kurokawa, M, Kirk, LP., Kirkpatric, K.A., Kase, H. and Richardson, P.J. (1994) \u201cInhibition by KF 17837 of adenosine receptor-mediated modulation of striatal GABA and ACh release\u201d,Br. J. Pharmacol. 113, 43\u201348.","journal-title":"Br. J. Pharmacol."},{"key":"BF03033210_CR45","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0014-2999(95)00498-X","volume":"287","author":"D.J.K.E. Lubitz von","year":"1995","unstructured":"von Lubitz, D.J.K.E., Lin, R.C.S. and Jacobson, K.A. (1995) \u201cCerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist\u201d,Eur. J. Pharmacol. 287, 295\u2013302.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033210_CR46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0163-7258(96)00119-2","volume":"72","author":"J. Mally","year":"1996","unstructured":"Mally, J. and Stone, T.W. (1996) \u201cPotential role of adenosine antagonist therapy in pathological tremor disorders\u201d,Pharmacol. Ther. 72, 243\u2013250.","journal-title":"Pharmacol. Ther."},{"key":"BF03033210_CR47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-2999(97)83039-7","volume":"328","author":"S.N. Mandhane","year":"1997","unstructured":"Mandhane, S.N., Chopde, C.T. and Ghosh, A.K. (1997) \u201cAdenosine A2 receptors modulate haloperidol-induced catalepsy in rats\u201d,Eur. J. Pharmacol. 328, 135\u2013141.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033210_CR48","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0306-4522(91)90038-P","volume":"42","author":"M.I. Martinez-Mir","year":"1991","unstructured":"Martinez-Mir, M.I., Probst, A. and Palacios, J.M. (1991) \u201cAdenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease\u201d,Neuroscience 42, 697\u2013706.","journal-title":"Neuroscience"},{"key":"BF03033210_CR49","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0165-0173(00)00033-3","volume":"33","author":"A. Mendonca de","year":"2000","unstructured":"de Mendonca, A., Sebastiao, A.M. and Ribeiro, J.A. (2000) \u201cAdenosine: does it have a neuroprotective role after all?\u201d,Brain Res. Rev. 33, 258\u2013274.","journal-title":"Brain Res. Rev."},{"key":"BF03033210_CR50","doi-asserted-by":"crossref","first-page":"8038","DOI":"10.1523\/JNEUROSCI.17-20-08038.1997","volume":"17","author":"C Moine Le","year":"1997","unstructured":"Le Moine, C, Svenningsson, P., Fredholm, B.B. and Bloch, B. (1997) \u201cDopamine-adenosine interactions in the striatum and globus pallidum: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances Dt receptor-mediated effects on c-foc expression\u201d,J. Neurosci. 17, 8038\u20138048.","journal-title":"J. Neurosci."},{"key":"BF03033210_CR51","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1097\/00001756-199812010-00034","volume":"9","author":"A. Monopoli","year":"1998","unstructured":"Monopoli, A., Lozza, G., Forlani, A., Mattavelli, A. and Ongini, E. (1998) \u201cBlockade of A2A adenosine receptors by SCH 58261 results in neuroprotective effect in cerebral ischemia in mice\u201d,NeuroReport 9, 3955\u20133959.","journal-title":"NeuroReport"},{"key":"BF03033210_CR52","first-page":"70","volume":"50","author":"A. Monopoli","year":"2000","unstructured":"Monopoli, A., Impagnatiello, R, Bastia, E., Fredduzzi, S. and Ongini, E. (2000) \u201cAnti-parkinsonian effects of selective A2A adenosine receptor antagonists in relevant rodent models\u201d,Drug Dev. Res. 50, 70\u201387.","journal-title":"Drug Dev. Res."},{"key":"BF03033210_CR53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-2999(94)90438-3","volume":"251","author":"M. Morelli","year":"1994","unstructured":"Morelli, M., Fenu, S., Pinna, A. and Di Chiara, G. (1994) \u201cAdenosine A2 receptors interact negatively with dopamine Di and D2 receptors in unilaterally 6-hydroxy-dopamine-lesioned rats\u201d,Eur. J. Pharmacol. 251, 21\u201325.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033210_CR54","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0306-4522(94)00602-2","volume":"67","author":"M. Morelli","year":"1995","unstructured":"Morelli, M., Pinna, A., Wardas, J. and Di Chiara, G. (1995) \u201cAdenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats\u201d,Neuroscience 67, 49\u201355.","journal-title":"Neuroscience"},{"key":"BF03033210_CR55","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1523\/JNEUROSCI.16-02-00605.1996","volume":"16","author":"A. Mori","year":"1996","unstructured":"Mori, A., Shindou, T., Ichimura, M., Nonaka, H. and Kase, H. (1996) \u201cThe role of adenosine A2A receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons\u201d,J. Neurosci. 16, 605\u2013611.","journal-title":"J. Neurosci."},{"key":"BF03033210_CR56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7258(99)00051-0","volume":"85","author":"M. Olah","year":"2000","unstructured":"Olah, M. and Stiles, G.L. (2000) \u201cThe role of receptor structure in determining adenosine receptor activity\u201d,Pharmacol. & Therap. 85, 55\u201375.","journal-title":"Pharmacol. & Therap."},{"key":"BF03033210_CR57","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0165-6147(96)80010-1","volume":"17","author":"E. Ongini","year":"1996","unstructured":"Ongini, E. and Fredholm, B.B. (1996) \u201cPharmacology of adenosine A2A receptors\u201d,Trends Pharmacol. Sci. 17, 364\u2013372.","journal-title":"Trends Pharmacol. Sci."},{"key":"BF03033210_CR58","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/(SICI)1098-2299(199811\/12)45:3\/4<387::AID-DDR39>3.0.CO;2-U","volume":"45","author":"E. Ongini","year":"1998","unstructured":"Ongini, E. and Schubert, P. (1998) \u201cNeuroprotection induced by stimulating Al or blocking A2A adenosine receptors: an apparent paradox\u201d,Drug Dev. Res. 45, 387\u2013393.","journal-title":"Drug Dev. Res."},{"key":"BF03033210_CR59","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/(SICI)1098-2299(199611\/12)39:3\/4<450::AID-DDR27>3.0.CO;2-3","volume":"39","author":"E. Ongini","year":"1996","unstructured":"Ongini, E., Dionisotri, S., Morelli, M., Ferre, S., Svenningsson, P., Fuxe, K. and Fredholm, B.B. (1996) \u201cNeuropharmacology of the adenosine A2A receptors\u201d,Drug Dev. Res. 39, 450\u2013460.","journal-title":"Drug Dev. Res."},{"key":"BF03033210_CR60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0304-3940(92)90498-V","volume":"138","author":"M.H. O\u2019Regan","year":"1992","unstructured":"O\u2019Regan, M.H., Simpson, R.E., Perkins, L.M. and Phillis, J.W. (1992) \u201cThe selective A2 agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex\u201d,Neurosci. Lett. 138, 169\u2013172.","journal-title":"Neurosci. Lett."},{"key":"BF03033210_CR61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0006-8993(95)01153-6","volume":"705","author":"J.W. Phillis","year":"1995","unstructured":"Phillis, J.W. (1995) \u201cThe effects of selective Aj and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil\u201d,Brain Res. 705, 79\u201384.","journal-title":"Brain Res."},{"key":"BF03033210_CR62","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1460-9568.1996.tb01285.x","volume":"8","author":"A. Pinna","year":"1996","unstructured":"Pinna, A., Di Chiara, G., Wardas, J. and Morelli, M. (1996) \u201cBlockade of A2a adenosine receptors positively modulates turning behaviour and c-Fos expression induced byDt agonists in dopamine-denervated rats\u201d,Eur. J. Neurosci. 8, 1176\u20131181.","journal-title":"Eur. J. Neurosci."},{"key":"BF03033210_CR63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/1098-2396(20010301)39:3<233::AID-SYN1004>3.0.CO;2-K","volume":"39","author":"A. Pinna","year":"2001","unstructured":"Pinna, A., Fenu, S. and Morelli, M. (2001) \u201cMotor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats\u201d,Synapse 39, 233\u2013238.","journal-title":"Synapse"},{"key":"BF03033210_CR64","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0006-8993(96)01036-0","volume":"743","author":"A.E. Pollack","year":"1996","unstructured":"Pollack, A.E. and Fink, J.S. (1996) \u201cSynergistic interaction between an adenosine antagonist and aD1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats\u201d,Brain Res. 743, 124\u2013130.","journal-title":"Brain Res."},{"key":"BF03033210_CR65","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-2999(94)90689-0","volume":"257","author":"P. Popoli","year":"1994","unstructured":"Popoli, P., Pezzola, A., Reggio, R. and Scotti de Carolis, A. (1994) \u201cModulation of striatal adenosine Al and A2 receptors induces rotational behavior in response to dopaminergic stimulation in intact rats\u201d,Eur. J. Pharmacol. 257, 21.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033210_CR66","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(95)00679-6","volume":"287","author":"P. Popoli","year":"1995","unstructured":"Popoli, P., Betto, P., Reggio, R. and Ricciarello, G. (1995) \u201cAdenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats\u201d,Eur. J. Pharmacol. 287, 215\u2013217.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033210_CR67","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0165-6147(97)01096-1","volume":"18","author":"P.J. Richardson","year":"1997","unstructured":"Richardson, P.J., Kase, H. and Jenner, P.G. (1997) \u201cAdenosine A2A receptor antagonists as new agents for the treatment of Parkinson\u2019s disease\u201d,Trends Pharmacol. Sci. 18, 338\u2013344.","journal-title":"Trends Pharmacol. Sci."},{"key":"BF03033210_CR68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0893-133X(97)00033-X","volume":"17","author":"R. Rimondini","year":"1997","unstructured":"Rimondini, R., Ferre, S., Ogren, S.O. and Fuxe, K. (1997) \u201cAdenosine A2A agonists: a potential new type of atypical antipsychotics\u201d,Neuropsychopharmacology 17, 81\u201391.","journal-title":"Neuropsychopharmacology"},{"key":"BF03033210_CR69","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/(SICI)1096-9861(19981116)401:2<163::AID-CNE2>3.0.CO;2-D","volume":"401","author":"D.L. Rosin","year":"1998","unstructured":"Rosin, D.L., Robeva, A., Woodard, R.L., Guyenet, P.G. and Linden, J. (1998) \u201cImmunohistochemical localization of adenosine A2A receptors in the rat central nervous system\u201d,J. Comp. Neurol. 401, 163\u2013186.","journal-title":"J. Comp. Neurol."},{"key":"BF03033210_CR70","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","volume":"283","author":"G.W. Ross","year":"2000","unstructured":"Ross, G.W., Abbott, R.D., Petrovitch, H., Morens, D.M., Grandinetti, A., Tung, K.-H., Tanner, CM., Masaki, K.H., Blanchette, PL., Curb, J.D., Popper, J.S. and White, L.R. (2000) \u201cAssociation of coffee and caffeine intake with the risk of Parkinson disease\u201d,J. Med. American Ass. 283, 2674\u20132679.","journal-title":"J. Med. American Ass."},{"key":"BF03033210_CR71","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0165-6147(92)90141-R","volume":"13","author":"K. Rudolphi","year":"1992","unstructured":"Rudolphi, K., Schubert, P., Parkinson, F.E. and Fredholm, B.B. (1992) \u201cNeuroprotective role of adenosine in cerebral ischaemia\u201d,Trends Pharmacol. Sci. 13, 439\u2013445.","journal-title":"Trends Pharmacol. Sci."},{"key":"BF03033210_CR72","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00008877-199404000-00006","volume":"5","author":"S. Schenk","year":"1994","unstructured":"Schenk, S., Valadez, A., Horger, B.A., Snow, S. and Wellman, P.J. (1994) \u201cInteraction between caffeine and cocaine in tests of self-administration\u201d,Behav. Pharmacol. 5, 153\u2013158.","journal-title":"Behav. Pharmacol."},{"key":"BF03033210_CR73","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1471-4159.1991.tb08257.x","volume":"57","author":"S.N. Schiffmann","year":"1991","unstructured":"Schiffmann, S.N., Jacobs, O. and Vanderhaeghen, J.J. (1991) \u201cThe striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons. An in situ hybridization histochemistry study\u201d,J. Neurochem. 57, 1062\u20131067.","journal-title":"J. Neurochem."},{"key":"BF03033210_CR74","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0301-0082(95)00035-6","volume":"48","author":"A.M. Sebastiao","year":"1996","unstructured":"Sebastiao, A.M. and Ribeiro, J.A. (1996) \u201cAdenosine A2A receptor-mediated excitatory actions on the nervous system\u201d,Prog. Neurobiol. 48, 167\u2013189.","journal-title":"Prog. Neurobiol."},{"key":"BF03033210_CR75","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0165-6147(00)01517-0","volume":"21","author":"A.M. Sebastiao","year":"2000","unstructured":"Sebastiao, A.M. and Ribeiro, J.A. (2000) \u201cFine-tuning neuromodulation by adenosine\u201d,Trends Pharmacol Sci. 21, 341\u2013346.","journal-title":"Trends Pharmacol Sci."},{"key":"BF03033210_CR76","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1098-2299(19960901)39:1<108::AID-DDR8>3.0.CO;2-J","volume":"39","author":"M.J. Sheardown","year":"1996","unstructured":"Sheardown, M.J. and Rnutsen, L.J.S. (1996) \u201cUnexpected neuroprotection observed with the adenosine A2A receptor agonist CGS 21680\u201d,Drug Dev. Res. 39, 108\u2013114.","journal-title":"Drug Dev. Res."},{"key":"BF03033210_CR77","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s002130051146","volume":"147","author":"S. Shiozaki","year":"1999","unstructured":"Shiozaki, S., Ichikawa, S., Nakamura, J., Kitamura, S., Yamada, K. and Kuwana, Y. (1999) \u201cActions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP\u201d,Psychopharmacology 147, 90\u201395.","journal-title":"Psychopharmacology"},{"key":"BF03033210_CR78","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1212\/WNL.25.8.722","volume":"25","author":"I. Shoulson","year":"1975","unstructured":"Shoulson, I. and Chase, T. (1975) \u201cCaffeine and the antiparkinsonian response to levodopa or pirebidil\u201d,Neurology 25, 722\u2013724.","journal-title":"Neurology"},{"key":"BF03033210_CR79","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1471-4159.1992.tb10041.x","volume":"58","author":"R.E. Simpson","year":"1992","unstructured":"Simpson, R.E., O\u2019Regan, M.H., Perkins, L.M. and Phillis, J.W. (1992) \u201cExcitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists\u201d,J. Neurochem. 58, 1683\u20131690.","journal-title":"J. Neurochem."},{"key":"BF03033210_CR80","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1046\/j.1460-9568.2000.00288.x","volume":"12","author":"I. Stromberg","year":"2000","unstructured":"Stromberg, I., Popoli, P., Muller, C, Feree, S. and Fuxe, J. (2000) \u201cElectrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2A receptor regulation in the rat dopamine-denervated striatum\u201d,Eur. J. Neurosci. 12, 4033\u20134037.","journal-title":"Eur. J. Neurosci."},{"key":"BF03033210_CR81","first-page":"15","volume":"50","author":"T.W. Stone","year":"2000","unstructured":"Stone, T.W. and Behan, W.M.H. (2000) \u201cAdenosine receptors, kynurenines and neuroprotection\u201d,Drug Dev. Res. 50, 15.","journal-title":"Drug Dev. Res."},{"key":"BF03033210_CR82","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/(SICI)1098-2396(199712)27:4<322::AID-SYN6>3.0.CO;2-E","volume":"27","author":"P. Svenningsson","year":"1997","unstructured":"Svenningsson, P., Hall, H., Sedvall, G. and Fredholm, B.B. (1997a) \u201cDistribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study\u201d,Synapse 27, 322\u2013335.","journal-title":"Synapse"},{"key":"BF03033210_CR83","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0306-4522(97)00046-8","volume":"79","author":"P. Svenningsson","year":"1997","unstructured":"Svenningsson, P., Nomikos, G.G., Qngini, E. and Fredholm, B.B. (1997b) \u201cAntagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens\u201d,Neuroscience 79, 753\u2013764.","journal-title":"Neuroscience"},{"key":"BF03033210_CR84","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","volume":"367","author":"U. Ungerstedt","year":"1971","unstructured":"Ungerstedt, U. (1971) \u201cPostsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigros-triatal dopamine system\u201d,Acta. Physiol. Scand. 367, 69\u201374.","journal-title":"Acta. Physiol. Scand."},{"key":"BF03033210_CR85","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF02244956","volume":"111","author":"S.V. Vellucci","year":"1993","unstructured":"Vellucci, S.V., Sirinathsinghji, D.J.S. and Richardson, P.J. (1993) \u201cAdenosine A2 receptor regulation of apomorphine-induced turning in rats with unilateral striatal dopamine denervation\u201d,Psychopharmacology 111, 383\u2013388.","journal-title":"Psychopharmacology"},{"key":"BF03033210_CR86","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1523\/JNEUROSCI.20-16-05949.2000","volume":"20","author":"N.R. Zahniser","year":"2000","unstructured":"Zahniser, N.R., Simosky, J.K., Mayfield, R.D., Negri, C.A., Hanania, T., Larson, G.A., Kelly, M.A., Grandy, D.K., Rubinstein, M., Low, M.J. and Fredholm, B.B. (2000) \u201cFunctional uncoupling of adenosine A2A receptors and reduced response to caffeine in mice lacking dopamine D2 receptors\u201d,J. Neurosci. 20, 5949\u20135957.","journal-title":"J. Neurosci."},{"key":"BF03033210_CR87","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0022-3565(25)12287-8","volume":"276","author":"C Zocchi","year":"1996","unstructured":"Zocchi, C, Ongini, E., Conti, A., Monopoli, A., Negretti, A., Baraldi, P.G. and Dionisotti, S. (1996) \u201cThe non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2A adenosine receptor antagonist\u201d,J. Pharmacol. Exp. Ther. 276, 389\u2013404.","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03033210\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T05:28:48Z","timestamp":1739251728000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03033210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":87,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["BF03033210"],"URL":"https:\/\/doi.org\/10.1007\/bf03033210","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"type":"print","value":"1029-8428"},{"type":"electronic","value":"1476-3524"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}